Emerge Law Firm’s Take On Lykos / FDA – MDMA is…….

On Friday, 8/9, the FDA released its decision to not approve MDMA-assisted therapy for PTSD, stirring ongoing debate in the psychedelic research community. Many in the field were optimistic when Lykos Therapeutics initially submitted their New Drug Application in Dec. 2023, pointing to promising Phase 3 trials showing that over 70% of participants no longer met PTSD […]